All In MedTech

Device Trial Radar · NCT06480227

Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence

A Randomized Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence

Last checked: Nov 19, 2026Latest source record: Jun 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 358 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

358

Planned (sponsor's estimate)

Start

Aug 28, 2024

Primary completion

Dec 31, 2028

Study completion Dec 31, 2030

Sponsor

Lead sponsor
NICHD Pelvic Floor Disorders NetworkResearch network
Sponsor type
Research network
Collaborators
Duke University; Kaiser Permanente; University of Chicago; University of Pennsylvania; University of Texas Southwestern Medical Center; Women and Infants Hospital of Rhode Island; RTI International; University of California, San Diego; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
First posted
Jun 28, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicentered, double-blind, randomized controlled, surgical trial of 358 women with inadequate symptom relief of stress urinary incontinence (SUI) or stress predominant mixed urinary incontinence (MUI) after conservative care. The Primary Aim is to determine the comparative effectiveness (as defined by "much" or "very much" better on PGI-I) of transurethral bulking agent (TBA) \[for 1 or 2 injections in 12 months\] vs. single-incision sling (SIS) 12 months after treatment intervention in women with predominant stress urinary incontinence (SUI).

Conditions

  • Stress Urinary Incontinence
  • Urinary Incontinence
  • Mixed Urinary Incontinence

Interventions

  • Solyx Single-incision SlingDevice

    Minimally invasive mesh device placed to treat stress urinary incontinence.

  • Bulkamid Transurethral Bulking AgentDevice

    Minimally invasive bulking agent injections used to bulk up the tissue surrounding the urethra to treat stress urinary incontinence. Up to 2 treatments within 12 months are allowed

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Subjective success measured by Patient Global Impression-Improvement [PGI-I] (>2) for TBA vs. SIS at 12 months.Time frame: At 12 months post-intervention.

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • University of California at San Diego

    La Jolla, California · Recruiting

  • Kaiser Permanente -- San Diego

    San Diego, California · Recruiting

  • University of Chicago

    Chicago, Illinois · Recruiting

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.